Agilent Technologies (A) vs Bruker (BRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bruker (BRKR) has outperformed Agilent Technologies (A) over the past year, gaining 72.8% versus a gain of 22.0%. Over five years, A leads with a +10.3% price change compared with -22.7% for BRKR. Agilent Technologies is the larger company by market cap ($46.58 billion vs $8.84 billion), about 5.3 times the size.
On valuation, Bruker trades at a lower forward P/E (24.1x vs 24.4x for Agilent Technologies). Agilent Technologies offers the higher dividend yield (0.61% vs 0.34%). Agilent Technologies converts more of its revenue into profit, with a net margin of 18.8% versus -0.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | A | BRKR |
|---|---|---|
| Share price | $165.19 | $58.05 |
| Market cap | $46.58B | $8.84B |
| 1-day change | -2.31% | -2.80% |
| YTD return | +24.27% | +26.77% |
| 1-year return | +22.03% | +72.80% |
| 5-year return | +10.32% | -22.67% |
| P/E ratio (TTM) | 32.58 | — |
| Forward P/E | 24.44 | 24.06 |
| EPS (TTM) | $5.07 | $-0.70 |
| Dividend yield | 0.61% | 0.34% |
| Annual dividend | $1.01 | $0.20 |
| Revenue (latest FY) | $6.95B | $3.44B |
| Revenue growth (YoY) | +6.73% | +2.08% |
| Net income (latest FY) | $1.30B | $-8.60M |
| Gross margin | 52.43% | 45.91% |
| Operating margin | 21.29% | 1.98% |
| Net margin | 18.75% | -0.25% |
| 52-week high | $177.05 | $66.98 |
| 52-week low | $108.35 | $32.37 |
| Distance from 52-week high | -6.70% | -13.33% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +6.85% | +8.96% |
| Average volume | 2.26M | 2.23M |
| Shares outstanding | 281.97M | 152.36M |
| Employees | 18,200 | 11,085 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Agilent Technologies is about 5.3 times larger than Bruker by market value ($46.58B vs $8.84B).
- BRKR has outperformed A by 50.8 percentage points over the past year.
- Agilent Technologies is more profitable, keeping 18.8 cents of every revenue dollar as net income versus -0.3 cents for Bruker.
About Agilent Technologies
A stock →Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Industrials · Biotechnology: Laboratory Analytical Instruments · 18,200 employees
About Bruker
BRKR stock →Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,085 employees
A vs BRKR FAQ
Which is bigger, Agilent Technologies or Bruker?
Agilent Technologies (A) is larger, with a market capitalization of $46.58B compared with $8.84B for Bruker (BRKR).
Which stock has performed better over the past year, A or BRKR?
BRKR returned +72.80% over the past 12 months, compared with +22.03% for A (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Agilent Technologies or Bruker?
Agilent Technologies has the higher yield at 0.61%, compared with 0.34% for Bruker.
Are Agilent Technologies and Bruker in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.